Peer-influenced content. Sources you trust. No registration required. This is HCN.

Medical Professionals Reference (MPR)ACIP: Updated Vaccine Guidance for the 2022-2023 Influenza Season

All vaccines are expected to be quadrivalent. Included in the update are expanded approval for Flucelvax Quadrivalent, administration adjustments for Afluria Quadrivalent, and higher dose vaccines for those 65 years old and older.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form